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Green tea consumption is associated with chemoprevention of many cancer types. Fresh
tea leaves are rich in polyphenolic catechins, which can constitute up to 30% of the dry
leaf weight. While the polyphenols of green tea have been well investigated, it is still
largely unknown, whether or not non-phenolic constituents also reveal chemopreventive
and anti-metastatic effects. In this study, we investigated the effects of a fraction of
green tea rich in phenolic compounds (PF), a non-phenolic fraction (NPF), which contains
glyceroglycolipids (GGL), and a pure glyceroglycolipid compound isolated from the
non-phenolic fraction in human cancer. Dried green tea leaves were extracted and
applied to a Sephadex LH-20 column. The resazurin reduction assay was used to
investigate the cytotoxicity of green tea samples toward human HepG2 hepatocellular
carcinoma and normal AML12 hepatocytes cells. Gene expression profiling was
performed by mRNA microarray hybridization and the microarray results were validated
by RT-PCR. The scratch migration assay was used to investigate the effects of green tea
samples on cell migration in vitro. The changes of microtubule dynamics were observed
using fluorescence microscopy. PF and NPF were prepared from methanol extract of
green tea. A GGL was isolated from NPF. All three green tea samples did not show
significant cytotoxic activity up to 10µg/mL in both HepG2 and AML12 cells, whereas
cytotoxicity of the control drug doxorubicin was observed with both cell lines (IC50
on AML12: 0.024µg/mL, IC50 on HepG2: 2.103µg/mL). We identified three sets of
genes differentially expressed upon treatment with the green tea samples. The genes
were associated with cytoskeleton formation, cellular movement, and morphology. The
correlation coefficients between mRNA expression values determined by microarray and
RT-PCR were R = 0.94. HepG2 and U2OS cells treated with green tea extracts showed
the delayed closures. Besides, the number of distinct tubulin filaments decreased upon
treatment with green tea samples. We identified not only PF, but also glyceroglycolipids
in NPF as contributing factors to the chemopreventive effects of green tea. Both PF and
NPF of green tea inhibited cancer cell migration by the disassembly of microtubules, even
though they were not cytotoxic.
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INTRODUCTION
Tea is one of the most popular beverages around the world.
It is obtained from the leaves of Camellia sinensis L. Kuntze
(Theaceae) as green, black, or oolong tea (Balentine et al., 1997;
Jankun et al., 1997). Fresh tea leaves are rich in polyphenols
known as catechins, which may constitute up to 30% of the
dry leaf weight (Cabrera et al., 2006; Chacko et al., 2010).
The most prominent catechins are epicatechin, epicatechin-3-
gallate, epigallocatechin, and epigallocatechin-3-gallate (EGCG)
(Sano et al., 2001; Cabrera et al., 2006; Chacko et al., 2010).
Other polyphenols include flavonols and their glycosides and
one compound unique to tea, theogallin (3-galloylquinic acid)
(Saleh et al., 2013). Green tea leaves contain three main classes
of compounds, which are known to affect human health, i.e.,
xanthic bases (caffeine and theophylline), essential oils, and
polyphenolic compounds (Graham, 1992). Caffeine is present at
an average level of 3% along with very small amounts of the
other common methylxanthines, theobromine, and theophylline
(Graham, 1992). The amino acid theanine (N5-ethylglutamine)
is also unique to tea (Graham, 1992). However, the nonphenolic
components of green tea have not been explored in detail and
their biological effects are unknown.
Several biological properties have been reported for green
tea such as anti-inflammatory, anti-arthritic, antimicrobial, anti-
oxidative, neuroprotective, antidiabetic, anti-angiogenic, and
anticancer effects (Chacko et al., 2010; Hosseini and Ghorbani,
2015). Green tea consumption has been linked to the prevention
of many types of cancer, including those of lung, colon,
esophagus, mouth, stomach, small intestine, kidney, pancreas,
and mammary glands (Chacko et al., 2010). Catechins are
considered to be responsible for most of the biological properties
of green tea (Bettuzzi et al., 2006; Chacko et al., 2010). In
a double-blind, placebo-controlled study, green tea catechins
were safe and effective for treating premalignant prostate cancer
(Bettuzzi et al., 2006). Several other studies also support the
protective effects of green tea against prostate, esophageal, colon,
rectum, and pancreatic cancers (Ji et al., 1997; Jian et al., 2004).
A protective effect of green tea against liver injury was also
supported by animal studies (Arteel et al., 2002; Abe et al., 2005,
2007).
Tea polyphenols are in general considered as strong
antioxidants, and the anti-oxidative activity of tea polyphenols
has been linked with decreased oxidative DNA damage. For
example, supplementation of the diet of heavy smokers with
green tea reduced urinary 8-hydroxydeoxy-2′-deoxyguanosine
(8-OHdG) compared with the control group (Hakim et al.,
2003; Schwartz et al., 2005). EGCG serves as hydrogen bond
donor and binds many proteins, e.g., fibronectin, fibrinogen and
histidine-rich glycoproteins, laminin receptor and Bcl-2 (Leone
et al., 2003; Tachibana et al., 2004; Umeda et al., 2008). EGCG
inhibited the phosphorylation of JNK (JUN N-terminal kinase),
JUN, MEK1, MEK2, ERK1, ERK2, and ELK1 (Ets-like protein
Abbreviations: 8-OhdG, 8-hydroxydeoxy-2′-deoxyguanosine; EGCG,
epigallocatechin-3-gallate; GGL, glyceroglycolipid; NPF, non-phenolic fraction;
PF, phenolic fraction; GFP, green fluorescence protein.
1) in JB6 epidermal cells (Dong et al., 1997; Chung et al., 1999,
2001). Besides, several studies demonstrated the inhibitory effects
of EGCG on the EGFR signaling pathways (Liang et al., 1997;
Hou et al., 2005; Shimizu et al., 2005; Adachi et al., 2007, 2008).
Inhibition of EGFR signaling also decreased VEGF A expression
in cancer cells (Masuda et al., 2002). These investigations clearly
demonstrate that the cancer-preventive effects of EGCG are
caused by multiple molecular mechanisms.
According to the multi-step model of carcinogenesis, tumors
develop in three main steps: (1) initiation, where persistent
DNA lesions occur, (2) proliferation stimuli in the promotion
phase, and (3) the progression phase, which includes genomic
instability, metastasis and neo-angiogenesis. Green tea and
EGCG inhibit not only initiation and promotion of the
carcinogenic process, but also progression (Park and Surh, 2004;
Rathore and Wang, 2012). While the polyphenols of green tea
have been well investigated, it is still largely unknown, whether or
not non-phenolic constituents also reveal chemopreventive and
anti-metastatic effects. Inhibition of invasion and cell migration
by EGCG as initial steps of metastasis have been reported for
cell lines of diverse types (Khan and Mukhtar, 2010). Less is
known, however, about inhibition of migration of liver cancer
cells by green tea extracts and the underlying mechanisms are not
understood in this tumor entity. Since hepatocellular carcinoma
has a high incidence in Southeast Asia (Goh et al., 2015) and
green tea is very popular in entire Asia, the exploration of the
chemopreventive effects of green tea extracts and their molecular
modes of action against liver cancer represents an obvious and
important topic.
In this study, we investigated possible targets and
mechanisms of chemopreventive action of green tea in
human HepG2 hepatocellular carcinoma cells. Our study
focused on investigating the efficacy of a fraction of green
tea rich in phenolic compounds, a non-phenolic fraction,
which contains glyceroglycolipids, and a pure compound
belonging to glyceroglycolipid class, which was isolated
from the non-phenolic fraction. For the systematic and
comprising search for underlying modes of action of green tea
constituents, we compared microarray-based, transcriptome-
wide mRNA expression profiles of treated vs. untreated cells.
Differentially expressed genes were subjected to pathway
profiling and the identified pathways were subsequently
experimentally verified by independent experimental
methods.
MATERIALS AND METHODS
Preparation of Green Tea Samples
Dried green tea leaves of Chirag Trade Mark were purchased in
Memphis TN. A reference (No. 4915) have been deposited at
the National Center for Natural Products Research, University
of Mississippi. The leaves were extracted with methanol at
room temperature. The dried methanol extract (28.8% w/w) was
partitioned between hexanes and methanol. After removal of
chlorophylls, the methanol extract was applied to a Sephadex
LH-20 column and eluted with methanol. The resultant fractions
were separated into non-phenolic fraction (NPF, 4.5% w/w) and
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phenolic fraction (PF, 18.7% w/w) based on TLC profiles. GGL, a
glyceroglycolipid was isolated from NPF.
NMR and Mass Data Analysis
NMR spectra were recorded in C5D5N on a Varian AS 400 or
Varian Unity Inova 600 NMR spectrometers. HRESIMS data
were obtained on an Agilent Series 1100 SL mass spectrometer.
Analysis Conditions for Catechin
Standards and Phenolic Fraction of Green
Tea Methanol Extract
The analysis was performed on a Waters Acquity UPLC system
(Waters Corp., Milford, MA) that included a binary solvent
manager, sampler manager, heated column compartment, photo-
diode array (PDA) detector, and single quadrupole detector
(SQD). The instrument was controlled by Waters Empower
2 software. A Waters UPLC Shield RP18 column (2.1 ×
100mm I.D., 1.7µm) was used. The column and sample
temperatures were maintained at 35◦C and 10◦C, respectively.
The eluent consisted of water containing 0.05% formic acid
(A) and acetonitrile with 0.05% formic acid (B). The analysis
was performed using the following gradient elution at a flow
rate of 0.25 mL/min: 0–2.0min, held at 2% B; 2.0–3.0min, 2%
B to 7% B; and 3.0–15.0min, 7% B to 25% B. The analysis
was followed by a 3min washing procedure with 100% B and
re-equilibration period of 4.5 min. All solutions were filtered
through 0.45µm PTFE filters. The injection volume was 2µL.
The PDA detection wavelength was 230 nm. An ESI source
was used in the positive mode. The source temperature and
the desolvation gas temperature were maintained at 150◦C and
350◦C, respectively. The probe voltage (capillary voltage), cone
voltage, and extractor voltage were fixed at 3.5 kV, 30V, and 3.0V,
respectively. Nitrogen was used as the desolvation gas (650 L/h)
and drying gas (25 L/h). Mass spectra were obtained at 500 Da/s
scan rate.
Analysis Conditions for Glyceroglycolipd
Standards and Non-phenolic Fraction of
Green Tea Methanol Extract
The analysis was performed on a Waters Acquity UPLC system
(Waters Corp., Milford, MA) that included a binary solvent
manager, sampler manager, heated column compartment, PDA
detector, and single quadrupole detector (SQD). The instrument
was controlled by Waters Empower 2 software. A Waters Cortec
UPLC C18 column (2.1 × 100 mm I.D., 1.6µm) was used.
The column and sample temperatures were maintained at 35◦C
and 10◦C, respectively. The eluent consisted of water containing
0.05% formic acid (A) and acetonitrile with 0.05% formic acid
(B). The analysis was performed using the following gradient
elution at a flow rate of 0.25mL/min: 0–7.0 min, 55% B to 95% B;
7.0–8.0min, 95% B to 100% B; and held at 100% B in next 4min.
The analysis was followed by a re-equilibration period of 4.5min.
All solutions were filtered through 0.45µm PTFE filters and the
injection volume was 5µL. The PDA detection wavelength was
200 nm. An ESI source was used in the positive mode. The
source temperature and the desolvation gas temperature were
maintained at 150 and 350◦C, respectively. The probe voltage
(capillary voltage), cone voltage, and extractor voltage were fixed
at 3.0 kV, 30 V, and 3.0 V, respectively. Nitrogen was used as the
desolvation gas (650 L/h) and drying gas (25 L/h). Mass spectra
were obtained at 500 Da/s scan rate.
Resazurin Reduction Assay
The resazurin reduction assay was used to investigate the
cytotoxicity of green tea samples toward human HepG2
hepatocellular carcinoma and normal AML12 hepatocytes cells.
The assay is based on reduction of the indicator dye, resazurin,
to the highly fluorescent resorufin by viable cells. Non-viable
cells rapidly lose the metabolic capacity to reduce resazurin and,
thus, do not produce fluorescent signal (O’Brien et al., 2000;
Seo et al., 2015). Briefly, adherent cells were detached by 0.25%
trypsin/EDTA (Invitrogen, Darmstadt, Germany) and 5000 cells
were placed in each well of a 96-well cell culture plate (Thermo
Scientific, Schwerte, Germany) in a total volume of 100µL. Cells
were attached overnight and then were treated with different
concentrations of test samples. After 72 h incubation, 20µL
resazurin (Sigma-Aldrich, Taufkirchen, Germany) 0.01% w/v in
ddH2O was added to each well and the plates were incubated
at 37◦C for 4 h. Fluorescence was measured by an Infinite
M2000 Proplate reader (Tecan, Crailsheim, Germany) using an
excitation wavelength of 544 nm and an emission wavelength of
590 nm. Each experiment was done at least three times, with six
replicates each. The cell viability was calculated as percentage of
untreated control.
mRNA Microarray
HepG2 cells were seeded and incubated for 24 h prior to
treatment with green tea sample (PF, NPF, or GGL). Cells
were treated with 25µg/mL of the test sample or DMSO
as solvent control (0.5%) for 24 h. Then, total RNA was
isolated using InviTrap Spin Universal RNA Mini kit (250)
(Stratec Molecular, Berlin, Germany). The experiment was
performed in duplicates for treated samples and for control
samples at the Institute for Molecular Biology (IMB) as
previously described (Wiench et al., 2012). The quality of
total RNA was confirmed by gel analysis using the total RNA
Nano chip assay on an Agilent 2100 Bioanalyzer (Agilent
Technologies, Berlin, Germany). Only samples with RNA index
values greater than 9.3 were selected for expression profiling.
RNA concentrations were determined using the NanoDrop
spectrophotometer (NanoDrop Technologies, Wilmington, DE).
Biotin-labeled cRNA samples for hybridization on Illumina
Human Sentrix-HT12 BeadChip arrays (Illumina, Inc., San
Diego, CA, USA) were prepared according to Illumina’s
recommended sample labeling procedure based on the modified
Eberwine protocol (Eberwine et al., 1992). In brief, 250–500
ng total RNA was used for complementary DNA (cDNA)
synthesis, followed by an amplification/labeling step (in vitro
transcription) to synthesize biotin-labeled cRNA according to
the Message Amp II a RNA Amplification kit (Ambion, Inc.,
Austin, TX). Biotin-16-UTP was purchased from Roche Applied
Science (Penzberg, Germany). The cRNA was column purified
according to Total Prep RNA Amplification Kit, and eluted in
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60–80µL of water. The quality of cRNA was controlled using
the RNA Nano Chip Assay on an Agilent 2100 Bioanalyzer
and spectrophotometrically quantified (NanoDrop). Subsequent
hybridization was performed according to the manufacturer’s
instructions. Microarray scanning was done using a Beadstation
array scanner, setting the adjustment to a scaling factor of 1
and photomultiplier tube settings at 430. Data extraction was
performed for all beads individually, and outliers were removed,
if the median absolute deviation exceeded 2.5. Then, mean
average signals and standard deviations were calculated for
each probe. Data analysis was done by normalization of signals
using the quantile normalization algorithm without background
subtraction. Differentially regulated genes were defined by
calculating the standard deviation differences of a given probe
in a one-by-one comparison of samples or groups. The data was
further processed using Chipster software (The Finnish IT Center
for Science CSC, Espoo, Finland).
Real-Time Reverse Transcription PCR
Real-time RT-PCR was performed with the same samples that
were used for microarray experiments. Total RNA was isolated as
described before and converted to cDNA with random hexamer
primers using RevertAid H Minus First Strand cDNA Synthesis
kit (Thermo Scientific, Waltham, MA, USA). PCR primers
for five genes (Table 1) were designed using Roche Universal
Probe Design (http://www.rocheapplied-science.com/sis/rtpcr/
upl/index.jsp?id=UP030000) and GenScript Real Time PCR
Primer Design (https://www.genscript.com/ssl-bin/app/primer)
tools. Amplification specificities were checked with Primer
Blast (http://www.ncbi.nlm.nih.gov/tools/primer-blast) using the
sequence data from the NCBI RefSeq Human mRNA database.
Oligonucleotides were synthesized by Eurofins MWG Operon
(Ebersberg, Germany). Primer sequences are shown in Table 1.
Real-time RT-PCR experiments were performed on CFX384
Real-Time PCR Detection System (Bio-Rad, Munich, Germany).
Four microliters of 5× Hot Start Taq EvaGreen qPCR Mix (no
ROX) (Axon, Kaiserslautern, Germany), 250 nM final primer
concentration and 300 ng RNA (converted to cDNA) were used
per reaction. RT-PCR was performed as follows: 50◦C for 2min,
initial denaturation at 95◦C for 10min, 40 cycles including strand
separation at 95◦C for 15 s, annealing at 56.5◦C for 1min, and
extension at 72◦C for 1min following final extension at 72◦C
for 1min. The housekeeping gene RPS13 served as reference for
standardization. All measurements were performed in duplicates.
Standardized Ct (cycle threshold) values for the genes in samples
were obtained by dividing the Ct values of genes in drug-treated
samples by Ct values of RPS13 gene and multiplying with the
Ct value of RPS13 in the DMSO control. Fold changes were
calculated with the 1Ct (standardized Ct of the gene in drug-
treated sample—Ct of the gene in DMSO control) method where
the fold change is equal to 2−1Ct for the up-regulated genes and
−(21Ct) for the down-regulated genes.
Ingenuity Pathway Analysis
Microarray data were analyzed through the use of IPA
(Ingenuity R© Systems, www.ingenuity.com). IPA software relies
on the Ingenuity Knowledge Base, a timely updated database
TABLE 1 | Primer nucleotide sequences used for real-time RT-PCR
experiments.
Target gene Primer sequences
CD86 Fw: 5′- ATTCTGAACTGTCAGTGCTTGC -3′
Rev: 5′- CTTCTTAGGTTCTGGGTAACCG -3′
ZNF365 Fw: 5′- GTTTGGCGTTGGCAGTCAGGTAAT -3′
Rev: 5′- CACAGCACGACTCTGCAAGTGTAT -3′
SYN1 Fw: 5′- AAC AGG CCG AAT TCT CTG AT -3′
Rev: 5′- CCA TTC CGA AGA ACT TCC AT -3′
STK11 Fw: 5′- TGA CTG TGG TGC CGT ACT TG -3′
Rev: 5′- CAC CGT GAA GTC CTG AGT GT -3′
RPS13 Fw: 5′- GGTTGAAGTTGACATCTGACGA -3′
Rev: 5′- CTTGTGCAACACATGTGAAT -3′
containing biological and chemical interactions and functional
annotations gathered from literature. In order to get information
about cellular functions, networks and affected pathways, the
Core Analysis tool of IPA was used for all datasets.
Scratch Migration Assay
The scratch migration assay was used to investigate the effects of
green tea samples on cell migration in vitro (Liang et al., 2007).
Briefly, 2 × 106 HepG2 cells or 1 × 106 U2OS-GFP-α-tubulin
cells were seeded in each well of a 6-well plate and allowed to
grow to a confluent monolayer for 24 h. The cell monolayer was
carefully scraped with a sterile p200 pipet tip to create a scratch.
Subsequently, cells were washed with PBS and DMEM culture
medium containing 25µg/mL of green tea sample (PF, NPF,
or GGL) or DMSO (solvent control) was added and incubated
further. Images of the scratches were taken after 48 h using a Juli
Br live cell analyzer (VWR International, Erlangen, Germany)
at 10× magnification. Data analysis was performed by TScratch
software (Gebäck et al., 2009).
Imaging of Structure and Dynamics of the
Microtubule Cytoskeleton by Fluorescence
Microscopy
2 × 104 U2OS-GFP-α-tubulin cells were seeded in each
well of a sterile ibi Treat µ-slide (ibidi, Germany) and
cells were allowed to attach overnight. Cells were treated
with 25 µg/mL of green tea sample (PF, NPF, or GGL)
or DMSO (solvent control) and incubated at 37◦C for 2 h.
After rinsing with PBS and staining for 15min with 300 nM
of 4′,6-diamidino-2-phenylindole (DAPI) (Life Technologies,
Darmstadt, Germany), the cells were washed with PBS and
mounted. Fluorescence imaging was performed by using 470 nm
excitation and 525 nm emission for GFP and 360 nm
excitation and 447 nm emission for DAPI of EVOS digital
inverted microscope (Life Technologies). Each experiment was
repeated at least three times and representative images were
selected.
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FIGURE 1 | UPLC-UV analysis of (A) phenolic fraction and (B) catechins standards (cross reference with Table 2).
FIGURE 2 | Chromatogram of non-phenolic fraction (cross reference with Table 3).
RESULTS
Green Tea Samples
Several glyceroglycolipids (2.0% of non-phenolic
fraction, NPF) were isolated from NPF. The isolated
compounds were identified, by NMR and mass data, as
3-[(1-oxohexadecyl)oxy]-2-[(1-oxooctadecyl)oxy]propyl-6-O-α-
D-galactopyranosyl β-D-galactopyranoside (GGL, 0.142% of
NPF); gingerglycolipid A (0.172% of NPF); (2S)-2-hydroxy-
3-[(1-oxohexadecyl)oxy]propyl 6-O- α-D-galactopyranosyl-
β-D-galactopyranoside (0.021% of NPF); (2S)-2-hydroxy-
3-[[(9Z,12Z,15Z)-1-oxo-9,12,15-octadecatrienyl]oxy]propyl-
β-D-galactopyranoside (0.11% of NPF); (2S)-2,3-
bis[[(9Z,12Z,15Z)-1-oxo-9,12,15-octadecatrienyl]oxy]propyl
6-O-α-D-galactopyranosyl-β-D-galactopyranoside (0.436%
of NPF); (2S)-2-[(1-oxohexadecyl)oxy]-3-[[(9Z,12Z,15Z)-
1-oxo-9,12,15-octadecatrienyl]oxy]propyl 6-O-α-D-
galactopyranosyl-β-D-galactopyranoside (0.645% of
NPF); (2S)-2-[[(9Z,12Z,15Z)-1-oxo-9,12,15-octadecatrien-
1-yl]oxy]-3-[(1-oxooctadecyl)oxy]propyl 6-O-α-D-
galactopyranosyl-β-D-galactopyranoside (0.105% of NPF);
and (2S)-2-[(1-oxohexadecyl)oxy]-3-[[(9Z,12Z,15Z)-1-oxo-
9,12,15-octadecatrien-1-yl]oxy]propyl 6-deoxy-6-sulfo-α-
D-glucopyranoside (0.130% of NPF). One of the isolated
glyceroglycolipids (GGL) was selected to be included in this
study. Eight catechins and caffeine were identified in PF
by UHPLC-UV-MS [(−)-gallocatechin (1.83% of Phenolic
Franction, (PF)), caffeine (2.71% of PF), epigallocatechin (14.5%
of PF), catechin (0.40% of PF), (−)-epicatechin (2.23% of PF),
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epigallocatechin gallate (46.9% of PF), gallocatehin gallate (0.81%
of PF), epicatechin gallate (8.55% of PF), and (−)-catechin gallate
(0.10% of PF)] (Figures 1, 2, Tables 2, 3).
Cytotoxic Effect of PF, NPF, and GGL and
Their Combinations (PF+NPF, PF+GGL,
NPF+GGL, and PF+NPF+GGL) toward
HepG2 Cancer Cells and AML12 Normal
Hepatocytes
In order to study the cytotoxicity of green tea samples toward
human hepatocellular carcinoma, HepG2 cells were treated
with PF, NPF, GGL or their combinations (PF+NPF, PF+GGL,
NPF+GGL, and PF+NPF+GGL) for 72 h up to a highest
concentration of 100µg/mL (PF and NPF), 25µg/mL (GGL),
12.5µg/mL of each sample for two sample combinations
(PF+NPF, PF+GGL, NPF+GGL) and 8.3µg/mL of each
sample in three extract combinations. Doxorubicin was used
as cytotoxic control drug in our resazurin reduction assay
in the range of 0.003–10µg/mL in order to compare its
cytotoxicity with those of green tea extracts. The effects in
HepG2 cancer cells were compared with those in AML12
normal hepatocytes. All three green tea samples did not
show significant cytotoxic activity up to 10µg/mL in the
resazurin assay, whereas cytotoxicity of doxorubicin was
observed with both cell lines (IC50 on AML12: 0.024 ±
0.003µg/mL, IC50 on HepG2: 2.103 ± 0.021µg/mL). However,
at the highest concentration (100µg/mL) of PF (containing
catechins and caffeine) a decrease in cell viability of both
AML12 and HepG2 cells was observed as seen in Figure 3B.
Cell viability of HepG2 and AML12 cells with treatment
of 100 µg/mL NPF was more than 60% (Figure 3C). 0–
25µg/mL of GGL did not show any cytotoxic effect in HepG2
and AML12 cells (Figure 3D). In the resazurin reduction
assays of combinations, cell viability decreased in AML12
cells with combinations of PF+NPF (each 12.5µg/mL) or
PF+GGL (each 12.5µg/mL) (Figure 3). However, cytotoxicity
was not observed, when PF+GGL (each 12.5µg/mL) or
PF+NPF+GGL (each 8.3µg/mL) were treated in both cell lines
(Figure 3).
TABLE 2 | Contents (% = mg/100mg sample) of catechins and caffeine in
phenolic fraction.
No. Compound name % in PF
1 (–)-Gallocatechin 1.83
2 Caffeine 2.71
3 Epigallocatechin 14.5
4 Catechin 0.40
5 (–)-Epicatechin 2.23
6 Epigallocatechin gallate 46.9
7 Gallocatehin gallate 0.81
8 Epicatechin gallate 8.55
9 (–)-Catechin gallate 0.10
Microarray Data
We performed gene expression analysis to identify possible
targets and mechanisms of action of green tea samples (PF, NPF,
and GGL) in HepG2 cells. To get information about cellular
functions, datasets were analyzed using the IPA Core Analysis
tool. We identified three sets of genes differentially expressed
upon treatment with the green tea samples. The genes were
associated with cytoskeleton formation, cellular movement and
morphology (Figure 4 and Tables 4, 5).
Validation of RNA Expression by Real-Time
RT-PCR
The microarray results were exemplarily validated by real-time
RT-PCR experiments and comparable results were obtained
(Table 6). The correlation coefficients betweenmRNA expression
values determined by microarray and real time RT-PCR were
R = 0.94 (Pearson correlation test). This indicated a high
degree of concordance between the results obtained by both
methods.
Inhibition of Cell Migration and Effect on
Microtubule Dynamics
Since we identified genes associated with cytoskeleton formation,
cellular movement, and morphology, we assumed that these
green tea samples may inhibit cell motility. Therefore, we
performed scratch migration assays with HepG2 and U2OS cells
(Figures 5, 6). Each cell has different characteristics. HepG2 cells
grow slowly and form a clump of cells instead of spreading
cells while cells are growing. Therefore, HepG2 cell layers
were not completely closed with the treatment of DMSO, the
negative control, after incubation for 72 h. HepG2 cell layers
treated with green tea extracts for 72 h showed interrupted
closures in contrast to treatment with DMSO (Figure 5). After
treatment of GGL, PF, and NPF for 72 h, HepG2 cell layers
were closed only by 19, 23, and 12% of the initial scratched
areas, respectively, whereas HepG2 cell layer treated with DMSO
for 72 h were closed by 55% of the initial scratch width
(Figure 5).
TABLE 3 | Contents of six glyceroglycolipid standards in non-phenolic
fraction NPF.
No. Compound name % in NPF
G1 Gingerglycolipid A 0.172
G2 (2S)-2-Hydroxy-3-[(1-oxohexadecyl)oxy]propyl
6-O-α-D-galactopyranosyl-β-D-galactopyranoside
0.021
G3 (2S)- 2-Hydroxy-3-[[(9Z,12Z,15Z)- 1-oxo-9,12,15-
octadecatrienyl]oxy]propyl-β-D-galactopyranoside
0.11
G4 (2S)-2,3-Bis[[(9Z,12Z,15Z)-1-oxo-9,12,15-
octadecatrienyl]oxy]propyl
6-O-α-D-galactopyranosyl-β-D-galactopyranoside
0.436
G5 (2S)-2-[(1-Oxohexadecyl)oxy]-3-[[(9Z,12Z,15Z)-1-oxo-9,12,15-
octadecatrienyl]oxy]propyl
6-O-α-D-galactopyranosyl-β-D-galactopyranoside
0.645
G6 (2S)-2-[[(9Z,12Z,15Z)-1-Oxo-9,12,15-octadecatrien-1-yl]oxy]-
3-[(1-oxooctadecyl)oxy]propyl
6-O-α-D-galactopyranosyl-β-D-galactopyranoside
0.105
Frontiers in Pharmacology | www.frontiersin.org 6 November 2016 | Volume 7 | Article 398
Seo et al. Green Tea Inhibits HepG2 Migration
FIGURE 3 | Cytotoxicity of green tea samples (A) doxorubicin, (B) PF, (C) NPF, (D) GGL, (E) PF+NPF, (F) PF+GGL, (G) NPF+GGL, and (H) PF+NPF+GGL
toward HepG2 hepatocellular carcinoma cells and AML12 normal hepatocytes. Significantly different between cell viability of doxorubicin and cell viability of
tested samples according to Student’s t-test, *0.01 < P ≤ 0.05, **P ≤ 0.01, blue for AML12 and red for HepG2 cells.
TABLE 4 | Top up- and down-regulated genes in HepG2 cells upon treatment of green tea samples (GGL, PF, or NPF) for 24h.
GGL PF NPF
Gene FCa Gene FCa Gene FCa
Top up-regulated genes UTF1 11.3 CD86 13.2 PCDH1 158.7
CD86 10.0 DKKL1 8.6 MAL 72.0
CCT3 8.9 DNAJC16 8.5 HDAC7 65.8
CTTNBP2 7.8 ZNF365 8.3 DNAH2 64.9
FHL1 7.7 NLRP1 7.6 MAPK8IP2 57.7
ZNF365 6.7 CYP4X1 7.3 ARL3 56.9
SYN1 5.7 SYN1 7.1 PELI2 56.9
POLR2J2/POLR2J3 5.5 CLDN5 6.6 GBP4 55.7
PRDX4 5.5 GPR179 6.0 NOX1 53.4
MYH8 5.3 RCSD1 5.5 DENND2A 52.0
Top down-regulated genes STK11 −29.0 VENTX −17.4 TALDO1 −1951.0
GPR126 −18.3 POT1 −8.7 LSM7 −1562.9
GLDC −15.3 PDZRN3 −8.4 NME2 −1530.7
GSN −14.5 PPAPDC1A −7.5 HLA-G −1184.4
HNRNPM −13.9 FHL1 −7.0 EEF1G −989.1
TMCO1 −13.3 SPO11 −6.2 NAB2 −982.3
DNAJC7 −13.3 SMG7 −5.4 ATPIF1 −897.6
RBM4 −13.1 NXN −5.2 NDUFA8 −861.1
GOLPH3 −11.2 TRPC2 −5.0 LOC645166 −765.4
SEC61G −10.9 AKT3 −4.6 RPS15 −760.1
aFC: fold change.
Fold changes of mRNA expression were detected by microarray hybridizations.
To investigate the effects of the green tea samples in more
details, we used U2OS cells stably transfected with a GFP fusion
construct of α-tubulin for scratch assays as well as observation
of microtubule dynamics (Figures 6, 7). In contrast to HepG2
cells, U2OS cells grow fast and are spreading, when they grow.
U2OS cell layer treated DMSO as solvent control showed a
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TABLE 5 | Cell migration-associated genes deregulated in HepG2 cells after treatment with GGL.
Functions Gene Description GGL PF NPF
Fold change
Cellular movement HBEGF Heparin-binding EGF-like growth factor −4.7 NCa NC
TGFBR1 Transforming growth factor, β-receptor 1 NC 2.5 NC
TGFBR2 Transforming growth factor, β-receptor 2 (70/80 kDa) −6.7 −2.8 NC
RAC1 Ras-related C3 botulinum toxin substrate 1 (rho family, small GTP binding protein
Rac1)
−3.2 NC NC
MAP3K7 Mitogen-activated protein kinase kinase kinase 7 −4.5 NC NC
PIM1 pim-1 oncogene −4.9 NC NC
RGS4 Regulator of G-protein signaling 4 3.8 2.9 NC
MYC v-myc myelocytomatosis viral oncogene homolog (avian) −8.3 −3.0 NC
PIM1 pim-1 oncogene −4.9 NC NC
PFN1 Profilin 1 −5.8 −2.8 NC
CDH11 Cadherin 11, type 2, OB-cadherin (osteoblast) NC −2.5 NC
CSPG4 Chondroitin sulfate proteoglycan 4 NC −2.7 NC
PKD1 Polycystic kidney disease 1 (autosomal dominant) NC −3.5 NC
AKT3 v-akt murine thymoma viral oncogene homolog 3 (protein kinase B, γ) NC −4.6 NC
BMPR2 Bone morphogenetic protein receptor, type II (serine/threonine kinase) NC 2.5 NC
PRKCI Protein kinase C, 1 NC −2.4 NC
PTP4A2 Protein tyrosine phosphatase type IVA, member 2 NC −2.8 NC
ADAM15 ADAM metallopeptidase domain 15 NC 3.2 NC
MYH10 Myosin, heavy chain 10, non-muscle NC 3.1 NC
STK11 Serine/threonine kinase 11 −29.0 NC −308.7
NME1 NME/NM23 nucleoside diphosphate kinase 1 NC NC −333.1
YBX1 Y box binding protein 1 NC NC −84.4
ARL3 ADP-ribosylation factor-like 3 NC NC 56.886
AURKA Aurora kinase A NC NC −70.5
BECN1 Beclin 1, autophagy related NC NC −84.4
CIT Citron (rho-interacting, serine/threonine kinase 21) NC NC −72.0
NUSAP1 Nucleolar and spindle associated protein 1 NC NC −58.5
RHOA Ras homolog family member A NC NC −82.1
TM4SF1 Transmembrane 4 L six family member 1 NC NC −69.1
TTC19 Tetratricopeptide repeat domain 19 NC NC −78.8
FOXP1 Forkhead box P1 NC NC −124.5
DEK DEK oncogene NC NC −40.8
GDF15 Growth differentiation factor 15 NC NC −57.7
CCL20 Chemokine (C-C motif) ligand 20 NC NC −116.2
C1QBP Complement component 1, q subcomponent binding protein NC NC −45.3
PGF Placental growth factor NC NC −259.6
BAG BCL2-associated athanogene NC NC −90.5
Cytoskeleton formation ARF6 ADP-ribosylation factor 6 −3.4 NC NC
ARHGEF10 Rho guanine nucleotide exchange factor (GEF) 10 3.4 NC NC
ARHGEF3 Rho guanine nucleotide exchange factor (GEF) 3 −2.9 NC NC
GNB1 Guanine nucleotide binding protein (G protein), β-polypeptide 1 −4.0 NC NC
GSN Gelsolin −14.5 NC NC
NCK1 NCK adaptor protein 1 −2.9 NC NC
PTPN11 Protein tyrosine phosphatase, non-receptor type 11 −3.7 NC NC
TGFBR2 Transforming growth factor, beta receptor 2 (70/80kDa) −6.7 NC NC
MAP3K7 Mitogen-activated protein kinase kinase kinase 7 −4.5 NC NC
(Continued)
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TABLE 5 | Continued
Functions Gene Description GGL PF NPF
Fold change
Morphology GOLPH3 Golgi phosphoprotein 3 (coat-protein) −11.2 −2.8 NC
HMGA1 High mobility group AT-hook 1 −2.9 NC NC
LETM1 Leucine zipper-EF-hand containing transmembrane protein 1 2.9 2.5 NC
PRDX3 Peroxiredoxin 3 −3.1 NC NC
SEC23IP SEC23 interacting protein −5.4 NC NC
MT1F Metallothionein 1F −6.2 −3.1 NC
KLF2 Kruppel-like factor 2 (lung) −3.8 NC NC
PIKFYVE Phosphoinositide kinase, FYVE finger containing −3.8 −2.6 NC
LZTS2 Leucine zipper, putative tumor suppressor 2 −4.8 NC NC
BST2 Bone marrow stromal cell antigen 2 −5.8 NC −286.0
BHLHE40 Basic helix-loop-helix family, member e40 −3.1 NC NC
TMEM123 Transmembrane protein 123 −9.1 NC NC
ABL1 c-abl oncogene 1, non-receptor tyrosine kinase −2.9 NC NC
EP300 E1A binding protein p300 −3.2 NC NC
CTSZ Cathepsin Z NC −3.9 NC
PRDX1 Peroxiredoxin 1 NC −2.8 NC
GPR18 G protein-coupled receptor 18 NC 5.2 NC
GPR182 G protein-coupled receptor 182 NC 5.1 NC
MMP10 Matrix metallopeptidase 10 (stromelysin 2) NC −2.4 NC
ARHGEF10 Rho guanine nucleotide exchange factor (GEF) 10 3.4 NC NC
ARHGEF3 Rho guanine nucleotide exchange factor (GEF) 3 −2.9 NC NC
GNB1 Guanine nucleotide binding protein (G protein), β-polypeptide 1 −4.0 NC NC
GSN Gelsolin −14.5 NC NC
NCK1 NCK adaptor protein 1 −2.9 NC NC
PTPN11 Protein tyrosine phosphatase, non-receptor type 11 −3.7 NC NC
SMARCA4 SWI/SNF related, matrix associated, actin dependent regulator of chromatin,
subfamily a,
NC NC −132.5
TGFBR2 Transforming growth factor, β-receptor 2 (70/80kDa) −6.7 NC NC
MAP3K7 Mitogen-activated protein kinase kinase kinase 7 −4.5 NC NC
PIM1 Pim-1 oncogene −4.9 NC NC
KPNA2 Karyopherin α 2 (RAG cohort 1, importin α 1) NC NC −39.9
NTM1 Nucleophosmin (nucleolar phosphoprotein B23, numatrin) NC NC −56.1
CTTN Cortactin NC NC −126.2
CSE1L CSE1 chromosome segregation 1-like (yeast) NC NC −109.1
RTN4 Reticulon 4 NC NC −132.5
LGALS3 Lectin, galactoside-binding, soluble, 3 NC NC −186.1
TYMS Thymidylate synthetase NC NC −181.0
aNC: no change.
complete scratch closure in most case after 48 h. However, cell
layer treated with each 25µg/mL of the three green tea samples
showed significantly delayed closures of the scratches. Only 17%
of the initial scratch width was closed up on treatment with
GGL after 48 h, while 42% and 33% of the initial scratch width
were recolonized upon treatment with PF and NPF after 48 h,
respectively (Figure 6). Our scratch assays with two different
cell lines clearly demonstrated that green tea samples inhibit cell
migration of both cell lines.
Microtubules are indispensable for the directional migration
of cells (Watanabe et al., 2005). Since our gene expression
profiling showed a high number of deregulated genes associated
with microtubule cytoskeleton, we treated U2OS-GFP-α-tubulin
cells with 25µg/mL of the samples or combinations of
three samples [PF+NPF (each 12.5µg/mL), PF+GGL (each
12.5µg/mL), NPF+GGL (each 12.5µg/mL), PF+NPF+GGL
(each 8.3µg/mL)], and analyzed their effect on microtubule
activity. The number of distinct tubulin filaments decreased
upon treatment with 25µg/mL of each green tea sample for
2 h (Figure 7). We also observed significantly decreased tubulin
filaments after treatment of all combined samples for 2 h
(Figure 7).
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FIGURE 4 | Identified molecular functions of (A) phenolic fraction, (B) non-phenolic fraction, and (C) glyceroglycolipid of green tea by Ingenuity
pathway analyses.
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TABLE 6 | Validation of microarray-based mRNA expression by quantitative real-time RT-PCR (RT-PCR were performed twice).
Cell line Gene Method Samples FC Samples FC
HepG2 CD86 Microarray hybridization GGL 9.99 PF 13.18
Real-time RT-PCR 5.19 9.57
HepG2 ZNF365 Microarray hybridization GGL 6.68 PF 8.28
Real-time RT-PCR 1.49 1.53
HepG2 SYN1 Microarray hybridization GGL 5.69 PF 7.06
Real-time RT-PCR 2.18 2.56
HepG2 STK11 Microarray hybridization GGL −29.04 NPF −308.69
Real-time RT-PCR −1.00 −16.32
R-value: 0.94 (Pearson correlation test).
FIGURE 5 | Inhibition of migration of HepG2 cells by green tea samples. HepG2 cells were treated with (A) DMSO for 0 h, (B) DMSO for 72 h, (C) phenolic
fraction for 0 h, (D) phenolic fraction for 72 h, (E) non-phenolic fraction for 0 h, (F) non-phenolic fraction for 72 h, (G) glyceroglycolipid for 0 h, (H) glyceroglycolipid for
72 h, (I) Quantification of closure of the scratch by TScratch software. Significantly different according to Student’s t-test, *P ≤ 0.05.
DISCUSSION
The aim of this study was to investigate the effects of
green tea constituents in human cancer cells. Similar to
previous studies, we also found abundant catechins in the
phenolic fraction (PF), e.g., 46.9% EGCG. NPF was also
analyzed by different chromatographic procedures and six
glyceroglycolipids were identified with an abundance of up to
2% in this fraction. One of the pure glyceroglycolipid, GGL
(0.142% of NPF) was characterized as 3-[(1-oxohexadecyl)oxy]-
2-[(1-oxooctadecyl)oxy]propyl-6-O-α-D-galactopyranosyl β-D-
galactopyranoside by NMR and mass data. This compound was
selected for further mechanistic study. The glyceroglycolipids
in green tea were identified and reported earlier (Ali et al.,
2010), but to the best of our knowledge there is no report of
their chemopreventive action in green tea. While EGCG and
other catechins in green tea attracted much attention in the past
years, non-phenolic compounds in this plant have been largely
neglected. Therefore, we investigated the effects of nonphenolic
components of green tea (NPF) and one of the isolated GGLs
toward human cancer and compared with the effects of well-
known PF containing catechins.
It has been reported that glyceroglycolipids showed tumor
suppressive effects (Murakami et al., 1995; Hou et al., 2007).
Hou et al. identified the bioactive glyceroglycolipid 1,2-di-
O-α-linolenoyl-3-O-β-galactopyranosyl-sn-glycerol (DLGG)
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FIGURE 6 | Inhibition of migration of U2OS-GFP-α-tubulin cells by green tea samples. U2OS-GFP-α-tubulin cells were treated with (A) DMSO for 0 h, (B)
DMSO for 72 h, (C) phenolic fraction for 0 h, (D) phenolic fraction for 72 h, (E) non-phenolic fraction for 0 h, (F) non-phenolic fraction for 72 h, (G) glyceroglycolipid for
0 h, (H) glyceroglycolipid for 72 h, (I) Quantification of closure of the scratch by TScratch software. Significantly different according to Student’s t-test, *P ≤ 0.05.
from Crassocephalum rabens (Asteraceae), which is a popular
herbal medicine and food supplement in Taiwan for various
inflammation-related syndromes and this glyceroglycolipid
can suppress NF-κB and its downstream inflammatory
mediators, NO, iNOS, COX-2, and prostaglandin E2, in vitro
(Hou et al., 2007). The anti-inflammatory effects of this
glyceroglycolipid might be also responsible for its significant
cancer chemopreventive activity (Hou et al., 2007). Besides,
two glyceroglycolipids were isolated from the leaves of Citrus
hystrix (bitter orange), a traditional herb in Thailand (Murakami
et al., 1995). They were identified as 1,2-di-O-α-linolenoyl-3-
O-β-galactopyranosyl-sn-glycerol (DLGG, 1) and a mixture
of two compounds, 1-O- α-linolenoyl-2-O-palmitoyl-3-O-
β-galactopyranosyl-sn-glycerol (2a) and its counterpart (2b)
(LPGG, 2). Both lipids were potent inhibitors of tumor promoter-
induced Epstein-Barr virus (EBV) activation (Murakami et al.,
1995). Therefore, we hypothesized that glyceroglycolipids in
green tea, which have not been investigated yet, may have
anti-tumor effects, therefore, they are worth to be tested.
Several biological properties have been reported for green tea,
including the prevention of cancer and cardiovascular diseases,
as well as anti-inflammatory, anti-arthritic, antibacterial,
antiangiogenic, anti-oxidative, antiviral, neuroprotective, and
cholesterol-lowering effects (Haqqi et al., 1999; Kavanagh
et al., 2001; Osada et al., 2001; Sueoka et al., 2001; Sartippour
et al., 2002; Donà et al., 2003; Raederstorff et al., 2003; Weber
et al., 2003; Sudano Roccaro et al., 2004; Weinreb et al., 2004).
Polyphenolic catechins were identified as active ingredients
(Bettuzzi et al., 2006; Chacko et al., 2010). In a double-blind
placebo-controlled study, green tea catechins were safe and
effective for treating premalignant prostate cancer (Bettuzzi
et al., 2006). Besides, clinical activity of green tea was shown
against prostate cancer (Jatoi et al., 2003; Choan et al., 2005).
Case-control studies supported the protective effect of green
tea against prostate, esophageal, colon, rectum and pancreatic
cancers (Ji et al., 1997; Jian et al., 2004).
In lieu of a number of previous studies reporting the
chemopreventive effects of green tea (Ji et al., 1997; Arteel et al.,
2002; Jian et al., 2004; Abe et al., 2005, 2007), we investigated
possible targets and mechanisms of action using microarray
analysis of green tea sample treated HepG2 hepatocellular
carcinoma cells. We found that the green tea samples at a
non-toxic or weakly cytotoxic concentration (25µg/mL) affected
molecular functions of cell morphology and cellular movement
and several cell migration-associated genes were identified.
PF, rich in catechins, deregulated several genes associated
with cellular movement and cell morphology functions. NPF
deregulated a number of genes related to cellular movement
and cell morphology with high fold changes. GGL isolated from
NPF was also effective in changing cell morphology and cellular
movement. Interestingly, it also deregulated genes related to
cytoskeleton formation.
Since deregulation of cell migration-associated genes was
shown for all three green tea samples, we validated our
microarray data by the scratch migration assay and fluorescence
microscopy of microtubule dynamics. Indeed, cell migration
was significantly inhibited and the number of tubulin filaments
were decreased by all three samples. These results indicate that
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FIGURE 7 | Live cell imaging of U2OS-GFP-α-tubulin cells stably transfected with a GFP fusion construct of α-tubulin cells and treated with (A) DMSO
or 25 µg/mL of green tea samples [(B) PF, (C) NPF, or (D) GGL], combinations of (E) PF+NPF (each 12.5 µg/mL), (F) PF+GGL (each 12.5 µg/mL), (G)
NPF+GGL (each 12.5 µg/mL), and (H) PF+NPF+GGL (each 8.3 µg/mL).
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green tea inhibit cell migration by the disruption of microtubule
cytoskeleton. These data indicate that not only PF of green tea
acts in a chemopreventive manner, but also the NPF with GGL as
one of its ingredients. As of yet, the filamentous proteins did not
attract much attention as possible targets for chemoprevention
by green tea.
Cytoskeletal elements such as tubulins, keratins, vimentin,
desmin, actin, and others represent widely distributed proteins
in eukaryotic cells with crucial functions for cell morphology,
motility, division, etc. (Lowery et al., 2015). Interestingly,
cytoskeletal proteins are also involved in signal transduction
and oncogenic signaling (Prendergast and Gibbs, 1993; Rao
and Li, 2004; Jiang et al., 2009). Lu et al. (2005) reported that
green tea extract modulated actin remodeling in a multi-step
carcinogenesis model. These results fit well to our observation
that PF, NPC, and GGL all affect cellular morphology and
movement as well as microtubule formation. Based on the results
obtained by us and Lu et al. (2005), it is reasonable to hypothesize
that cytoskeletal proteins may represent interesting targets for
chemoprevention and cancer therapy by green tea.
In our study, we observed that green tea samples were not
very toxic toward both HepG2 cancer cells and AML12 normal
hepatocytes. Cell viability was decreased with combinations of
PF+NPF, PF+GGL in AML12 cells, however, combination of all
three samples did not show any cytotoxic effect in both cells. It is
remarkable that the inhibition of cellular movement, migration,
and microtubule formation took place at concentrations, which
were not or only minimally cytotoxic against both liver cancer
cells and normal hepatocytes. Therefore, it can be expected
that these green tea extracts would not exert considerable
toxic side effects in normal tissues of cancer patients. Having
in mind the tremendous life-threatening side effects of most
chemotherapeutic drugs, it would be desirable to have anti-
invasive and anti-metastatic drugs available that are safe and
tolerable without severe side effects.
In conclusion, we identified not only PF, but also a
glyceroglycolipid in NPF as contributing factor to the
chemopreventive effects of green tea. Both PF and NPF of
green tea inhibited cancer cell migration by the disassembly of
microtubules, even though they were not cytotoxic. Hence, green
tea may have a high potential for application in the prevention of
human cancers.
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